alendronate has been researched along with sulfasalazine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Ballester, I; Daddaoua, A; López-Posadas, R; Martínez-Augustin, O; Nieto, A; Sánchez de Medina, F; Suárez, MD; Zarzuelo, A | 1 |
Liu, XY; Zhang, LL; Zhao, JX | 1 |
Ahmed, K; Khan, I; Mohiuddin, T; Rohman, N; Selvaraj, R; Skelton, AA; Yamin, M | 1 |
1 review(s) available for alendronate and sulfasalazine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for alendronate and sulfasalazine
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
The bisphosphonate alendronate improves the damage associated with trinitrobenzenesulfonic acid-induced colitis in rats.
Topics: Administration, Oral; Alendronate; Animals; Anti-Inflammatory Agents; Body Weight; Bone Density Conservation Agents; Chemokine CCL2; Colitis; Colon; Diphosphonates; Dose-Response Relationship, Drug; Female; Gastrointestinal Agents; Gene Expression; Injections, Intraperitoneal; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Rats; Rats, Wistar; Sulfasalazine; Treatment Outcome; Trinitrobenzenesulfonic Acid | 2007 |
Successful treatment of SAPHO syndrome with severe spinal disorder using entercept: a case study.
Topics: Acquired Hyperostosis Syndrome; Alendronate; Antirheumatic Agents; Bone Density Conservation Agents; Drug Therapy, Combination; Etanercept; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Middle Aged; Pain Management; Radiography; Receptors, Tumor Necrosis Factor; Spinal Diseases; Sulfasalazine; Treatment Outcome | 2012 |
Theoretical insights and implications of pH-dependent drug delivery systems using silica and carbon nanotube.
Topics: Acetaminophen; Alendronate; Drug Delivery Systems; Hydrogen-Ion Concentration; Ibuprofen; Nanotubes, Carbon; Quartz; Silicon Dioxide; Sulfasalazine | 2023 |